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ABSTRACT: In this study, the distribution of labeled dendrimers in native
and aneurysmal rat aortic tissue was examined. Adult male rats under-
went infrarenal aorta perfusion with generation 5 (G5) acetylated Alexa
Fluor 488-conjugated dendrimers for varying lengths of time. In a second
set of experiments, rats underwent aortic elastase perfusion followed by
aortic dendrimer perfusion 7 days later. Aortic diameters were measured
prior to and postelastase perfusion, and again on the day of harvest. Aor-
tas were harvested 0, 12, or 24 h postperfusion, fixed, and mounted. Na-
tive aortas were harvested and viewed as negative controls. Aortic cross-
sections were viewed and imaged using confocal microscopy. Dendrimers
were quantified (counts/high-powered field). Results were evaluated by
repeated measures ANOVA and Student’s t-test. We found that in native
aortas, dendrimers penetrated the aortic wall in all groups. For all per-
fusion times, fewer dendrimers were present as time between dendrimer
perfusion and aortic harvest increased. Longer perfusion times resulted
in increased diffusion of dendrimers throughout the aortic wall. By 24
h, the majority of the dendrimers were through the wall. Dendrimers in
aneurysmal aortas, on day 0 postdendrimer perfusion, diffused farther
into the aortic wall than controls. In conclusion, this study documents
labeled dendrimers delivered intra-arterially to native rat aortas in vivo,
and the temporal diffusion of these molecules within the aortic wall. In-
creasing perfusion time and length of time prior to harvest resulted in
continued dendrimer diffusion into the aortic wall. These preliminary
data provide a novel mechanism whereby local inhibitory therapy may
be delivered locally to aortic tissue.
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BACKGROUND
Local drug delivery has been used to treat many diseases. Local intra-arterial
drug delivery is difficult because it may be diluted away from the target site
rapidly due to high pressure and flow within the arteries.1 In one study, extracel-
lular matrix (ECM)-directed local drug delivery was achieved via a polylysine
vehicle for treating restenosis in the vessel wall. This was done by maintain-
ing a high concentration of the drug within the target tissue.2 An alternative
drug carrier that has not previously been used to deliver agents to aortic tis-
sue is a poly(amidoamine) (PAMAM) dendrimer. PAMAM dendrimers have
been used as carriers for delivering drugs in cancer therapies.3 PAMAM den-
drimers can also be used as imaging agents in humans.4 Their multifunctional
structure makes them appealing for drug delivery applications.5 In addition,
to be useful in biological systems, materials need to be biocompatible and wa-
ter soluble.6 Dendrimers are synthetic and very biocompatible with a highly
branched structure (FIG. 1).5 This structure allows for the attachment of multi-
ple agents by covalent linkage or by encapsulation.4 In this study, dendrimers
were acetylated to neutralize some of the primary amine groups and to reduce
nonspecific binding. Their shapes and sizes are well defined and uniform, and
their surfaces are readily chemically functionalized and modifiable.5,7
One potential clinical application for these dendrimers is targeted drug de-
livery for treating abdominal aortic aneurysms (AAAs). AAAs are the 10th
leading cause of death of men and the 14th leading cause of overall death in the
United States.8 Although there are currently no proven effective nonsurgical
medical therapies to treat patients with AAAs, doxycycline has been shown to
limit the enlargement of experimental AAAs9–12 and decrease levels of plasma
matrix metalloproteinase 9 (MMP-9), an enzyme known to degrade the aortic
wall in patients with AAAs.13 By delivering locally rather than systemically,
required doses of compounds such as doxycycline could be reduced, thereby
eliminating the risk of unwanted side effects.
In this study, generation 5 (G5) acetylated Alexa Fluor 488-conjugated den-
drimers were delivered intra-arterially to native and aneurysmal aortas to ex-
amine the diffusion of these labeled dendrimers through the aortic wall.
METHODS
Adult male Sprague–Dawley rats weighing 190–210 g were obtained from
Charles River Laboratories (Wilmington, MA, USA) and were used for all
experiments in this study. Surgical procedures and experiments were approved
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FIGURE 1. Structure of dendrimer. Dendrimer synthesis is attained via stepwise ad-
ditions and reactions; each layer is referred to as a “generation.” In this study, generation 5
dendrimers were partially acetylated and conjugated to Alexa Fluor 488 molecules.3
by the University of Michigan Universal Committee on the Use and Care of
Animals, per Protocol #8833.
Rodent Elastase Perfusion AAA Model
Rats were anesthetized with 2–3% isoflurane with 100% oxygen. Using
sterile techniques, a ventral midline incision was made. The infrarenal ab-
dominal aorta was isolated and perfused with pancreatic porcine elastase as
previously described (FIG. 2 A, B).14 Briefly, the aorta was exposed from the
iliac bifurcation (distal) to the level of the left renal vein (proximal), and all
side branches within the exposed length of the aorta were tied off with 7–0
silk suture (Ethicon Inc., Somerville, NJ, USA) to ensure pressurization of the
aorta. Using 4–0 cotton suture (Genzyme Corp., Fall River, MA, USA) and a
vascular clip, temporary distal and proximal aortic control was obtained. A 30-
gauge needle was used to make an aortotomy just proximal to the iliac bifur-
cation. A polyethylene-10 (PE-10) tube was inserted through the aortotomy,
and pancreatic porcine elastase (6 units/mL; Lot Number 083K7655; Sigma,
St. Louis, MO, USA) was infused into the isolated infrarenal aorta for 30 min.
Following perfusion, a 10–0 nylon monofilament suture (Surgical Specialties
Corp., Reading, PA, USA) was used to repair the aortotomy in the aorta.
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FIGURE 2. (A) Schematic of dendrimer and elastase perfusion setup. (B) Image of
elastase-perfused aortic aneurysm.
Images were taken using a Spot Insight Color Optical Camera (Diagnostic
Instruments, Sterling Heights, MI, USA) that was attached to the operating
microscope (Nikon, Melville, NY, USA), and aortic diameters were measured
using Image Pro Express Software (Media Cybernetics Inc., Silver Spring, MD,
USA). To close the abdomen, a 3–0 vicryl suture (Ethicon Inc., Somerville,
NJ, USA) was used and the rats were allowed to recover.
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Dendrimer Perfusion
The design and synthesis of the G5 acetylated Alexa Fluor 488-conjugated
dendrimers (molecular weight of 27,000 g/mol) are described according to
Majoros et al.3 To improve water solubility, and decrease aggregation and
nonspecific delivery of these dendrimers, the terminal primary amino func-
tionality was acetylated.15,16 Nonacetylated primary amino groups were used
for conjugation of Alexa Fluor 488, an imaging agent.3,17
Experiment 1
Rats were anesthetized as described above for elastase perfusion, and un-
derwent infrarenal aortic perfusion with G5 acetylated Alexa Fluor 488-
conjugated dendrimers (200 nM in 1X PBS) at a rate of 2 mL/h for varying
lengths of time (10, 30, 60 min; n = 4 per perfusion time). Upon dendrimer
perfusion, blood was allowed to flush out excess dendrimer solution. Aortas
were harvested 0, 12, or 24 h postperfusion (n = 4 per time point).
Experiment 2
Rats were anesthetized and underwent infrarenal aortic elastase perfusion.
Seven days following elastase perfusion, rats underwent aortic dendrimer per-
fusion as described above. Seven and 8 days postelastase perfusion, rats were
anesthetized, infrarenal aortas were exposed, and aortic diameters were mea-
sured prior to aortic explantation.
For all experiments, upon harvesting, aortic tissue was rinsed with 1X PBS,
pH 7.2–7.4, fixed in formalin (10%) for 1 h at room temperature, and mounted
in ProLong Gold Antifade Reagent (Molecular Probes, Eugene, OR, USA).
Aortic cross-sections were viewed and imaged using confocal microscopy.
Dendrimers were quantified within the aortic wall by manually counting them
in captured images, and are presented as dendrimers per high-powered field.
Native aortas (i.e., not perfused with dendrimers) were harvested and viewed
as negative controls.
RESULTS
Dendrimer Diffusion in Native Aortas
In native aortas, dendrimers penetrated the aortic wall at all time points. For
all perfusion times, fewer dendrimers were present as time between dendrimer
perfusion and aortic harvest increased (TABLE 1, FIG. 3). Longer perfusion
times resulted in increased diffusion of dendrimers throughout the aortic wall.
By 24 h, the majority of the dendrimers were through the wall.
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TABLE 1. Dendrimer quantification and location in normal aortic tissue
Perfusion Time before Average ± SEM
time (min) harvest (h) number of dendrimers∗ Location of dendrimers
10 0 99 ± 21 Media
10 24 61 ± 4 Mostly media, some adventitia
30 0 71 ± 7 Inner media
30 12 60 ± 4 Adventitia
30 24 35 ± 1 Adventitia
60 0 46 ± 2 Outer media, adventitia
60 12 34 ± 1 Adventitia
∗Mean counts from four samples per group.
When native aortas were perfused for 10 min, dendrimers were concentrated
in the media (toward lumen) on day 0, and in the media and adventitia 24 h
postperfusion. More dendrimers were present on day 0 than 24 h postperfu-
sion. Upon perfusing normal aortas for 30 min with dendrimer, the majority
of the dendrimers were in the media on day 0, and in the adventitia 12 h and
24 h postperfusion. There were fewer dendrimers present 12 h postperfusion
compared with day 0, and even fewer on 24 h postperfusion. After a 60-min
perfusion of normal aortas, the dendrimers were primarily in the media (to-
ward adventitia) and in the adventitia at day 0, and only in the adventitia
12 h postperfusion. Representative images of dendrimer-perfused normal aor-
tas on day 0 are shown in FIGURE 4. Native aortas that were not perfused with
dendrimers were harvested and demonstrated no fluorescence.
FIGURE 3. Dendrimer quantification in normal aortic tissue.
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FIGURE 4. Dendrimer-perfused normal aorta on day 0, 10 min perfusion (A) day 0,
30 min perfusion (B) day 0, 60 min perfusion (C) 40×.
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FIGURE 5. Percent increase in aortic diameter in elastase-perfused aortas postperfu-
sion and 7 days following perfusion. Each curve represents one animal. All animals formed
AAAs (defined as 100% increase in diameter) on postoperative day 7.
Experimental AAA Formation
The mean percentage increase (±SEM) in aortic diameter in the aneurysmal
aortas 7 days following elastase perfusion was 121 ± 10% (FIG. 5). Each animal
formed an aneurysm (defined as 100% increase in aortic diameter) by day 7
postelastase perfusion.
Dendrimer Diffusion in Aneurysmal Aortas
In aneurysmal aortas, dendrimers diffused farther into the aortic wall than in
control aortas (30 min perfusion time, day 0 harvest). Fewer dendrimers were
present in aortas that were harvested 24 h postdendrimer perfusion than when
harvested immediately (FIG. 6). By 24 h, the majority of the dendrimers were
through the wall.
Upon perfusing aneurysmal aortas (day 7 postelastase perfusion) for 30 min
with dendrimer, the majority of the dendrimers were in the adventitia on both
days 7 and 8 (postelastase perfusion). At both time points, dendrimers in
aneurysmal tissue diffused farther out than in native tissue (TABLE 2). Repre-
sentative images of dendrimer-perfused aneurysmal aortas on day 0 are shown
in FIGURE 7.
302 ANNALS NEW YORK ACADEMY OF SCIENCES
FIGURE 6. Dendrimer-perfused aneurysmal aorta on day 7 postelastase perfusion and
harvested on day 7, 30 min perfusion (A) and day 8, 30 min perfusion (B), 40×.
DISCUSSION
The objective of this study was to determine if dendrimers could be delivered
intra-arterially to normal and aneurysmal rat aortas in vivo, and to examine the
distribution of the labeled dendrimers within the aortic wall. This preliminary
study indicates that labeled dendrimers diffuse into the aortic wall from the
lumen. These dendrimers are not specific to the aorta, but at early times since
they are delivered intra-arterially remain in the aortic wall and do not diffuse
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TABLE 2. Dendrimer quantification and location in aneurysmal aortic tissue
Perfusion Time before Average ± SEM
time (min) harvest (h) number of dendrimers∗ Location of dendrimers
30 0 50 ± 13 Adventitia
30 24 34 ± 9 Adventitia
∗Mean counts from four samples per group.
out into other tissues. Both normal and aneurysmal aortic tissues are permeable
enough to allow for the passage of nanoparticles through the wall. Addition-
ally, varying dendrimer perfusion times, and lengths of time between dendrimer
perfusion and explantation affected the concentration gradient-dependent dif-
fusion patterns.
Several factors likely influenced the distribution of the dendrimers, including
the pressure within the isolated portion of the aorta during dendrimer perfu-
sion, the resistance of the aortic tissue, and any convective forces present in
the aorta. The physical and chemical properties of the dendrimers contribute to
their diffusion patterns in the aortic wall. These dendrimers diffuse into the aor-
tic wall because of their small size, and are attractive for local delivery of agents
since they are biocompatible and have a highly branched structure, allowing
for the attachment of multiple agents.5 For the present study, dendrimers were
acetylated to neutralize some of the primary amine groups. Their shapes and
sizes are well defined and uniform, and their surfaces are readily chemically
functionalized and modifiable.5,7 The pressure within the isolated portion of
FIGURE 7. Dendrimer quantification in aneurysmal aortic tissue (normal data shown
for comparison).
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the aorta during dendrimer perfusion and any convective forces present in the
aorta were similar in the native and aneurysmal aortas.18 However, due to the
remodeling of the aortic ECM during AAA formation, the change in the resis-
tance of the aortic tissue most likely contributed to the different distribution
patterns seen in the normal and aneurysmal tissue samples.
These preliminary results warrant further investigation of the use of den-
drimers for targeted drug delivery, especially in the area of AAA, where there
are no proven effective medical therapies. Because of their biocompatibility
and ability to attach these particles to a wide variety of agents, their poten-
tial as drug-carrying vehicles is excellent. The size of these dendrimers also
makes them good candidates for delivering these agents. In previous studies,
liposomes with a mean diameter of approximately 500 nm represented the
maximum size that could be used for drug delivery.19
Future experiments may include binding agents to dendrimers, and deliver-
ing them intra-arterially to experimental AAAs during development and fol-
lowing formation of small AAAs. Candidate agents include: (1) doxycycline,
which has been shown to inhibit formation of experimental AAAs9–12 and slow
the growth of small AAAs in humans13 and (2) 17-beta estradiol, which has
been shown to inhibit the development of experimental AAAs.20
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